Acronyms that contain the term CVRX 

CVRx

CVRx is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, that cannot be controlled with medications (refractory or resistant hypertension). The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is well financed and supported by an outstanding board of directors. They have established a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension. Hypertension affects over72 million people in the United States and is estimated to cause 1 in every 8 deaths worldwide. It is a major risk factor for cardiovascular disease, morbidity and mortality. It is a costly disease and yearly costs to treat hypertension in the United States are estimated to be $59.7 billion. Approximately 25 percentof people with hypertensioncannot adequately control their hypertension with medications and lifestyle modifications. It is a disease that needs new treatment solutions. The CVRx product provides a "physiological rational" method to reduce blood pressure. The system's proprietary technology uses the body's own natural blood pressure regulation system (baroreflex) to control blood pressure. CVRx has a strong intellectual property foundation, which will protect the unique hypertension therapy the company is developing. This product is currently under clinical evaluation in Europe and the United States.

see more »